Dr. Drew Michael is a board certified clinical molecular geneticist and clinical biological geneticist. In his current position as a Oncology Laboratory Director at Natera Inc, Dr. Michael oversees circulating tumor DNA minimal residual disease testing for patients and multiple clinical trials. Previously Dr. Michael served as an Assistant Professor of Genomics and Precision Medicine, Pathology, and Pediatrics at George Washington University in Washington D.C. and as a Director of Molecular and Biochemical Diagnostics at Children's National Hospital.